Advertisement

Topics

Cyclacel Announces Selection of Recommended Phase 2 Dose for CYC065 and Evidence of Durable ...

02:00 EDT 7 Aug 2017 | BioMedReports - Blog

BERKELEY HEIGHTS, N.J., Aug. 07, 2017 (GLOBE NEWSWIRE)

Read more...

Original Article: Cyclacel Announces Selection of Recommended Phase 2 Dose for CYC065 and Evidence of Durable ...

NEXT ARTICLE

More From BioPortfolio on "Cyclacel Announces Selection of Recommended Phase 2 Dose for CYC065 and Evidence of Durable ..."

Quick Search
Advertisement